
Change Healthcare is a wholly owned subsidiary of UnitedHealth Group (NYSE: UNH), which acquired the company in October 2022 for approximately $13 billion. Change Healthcare processes approximately 15 billion healthcare claim transactions annually, serving hundreds of thousands of physicians, pharmacies, and hospitals across the United States. In February 2024, Change Healthcare suffered the largest healthcare data breach in U.S. history, affecting approximately 192.7 million individuals. UnitedHealth Group is headquartered in Minnetonka, Minnesota.
Parent Company
Acquired
2022
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Change Healthcare | UnitedHealth Group | Wholly owned |
Change Healthcare was formed in 2013 through the merger of Emdeon, a healthcare technology and communications company, and Altegra Health, a provider of payment accuracy and risk adjustment solutions. The merger created one of the largest healthcare technology companies in the United States, focused on claims processing, payment management, and revenue cycle management.
Emdeon, the larger predecessor entity, was itself the product of multiple acquisitions. Originally founded as HPS in 1990, the company went through several ownership changes and rebrandings. In 2005, the company was acquired by Sage Capital and renamed Emdeon. Emdeon went public in 2009 and was taken private again in 2011 by Blackstone Group for approximately $3 billion. Under Blackstone ownership, Emdeon acquired several healthcare technology companies to build out its platform.
After the 2013 merger that created Change Healthcare, the company continued to grow through acquisitions. In 2016, Change Healthcare merged with the healthcare technology division of McKesson Corporation, creating a joint venture valued at approximately $3.1 billion. McKesson held approximately 70% of the combined entity, with the remainder held by Blackstone. The merged company adopted the Change Healthcare name and went public on the Nasdaq in June 2019 under ticker CHNG.
As an independent public company, Change Healthcare provided technology solutions including claims processing, payment accuracy, network management, and revenue cycle management. The company processed approximately 15 billion healthcare transactions annually and served approximately 2,200 payers and 5,500 hospitals. Change Healthcare's technology was deeply embedded in the U.S. healthcare system's financial infrastructure, handling approximately one-third of all healthcare claims in the United States.
In January 2021, UnitedHealth Group announced its agreement to acquire Change Healthcare for approximately $13 billion, including approximately $8 billion in cash and the assumption of approximately $5 billion in debt. The acquisition faced significant antitrust scrutiny from the U.S. Department of Justice, which filed a lawsuit in February 2022 to block the deal on grounds that it would reduce competition in healthcare technology markets. A federal judge ruled in UnitedHealth Group's favor in September 2022, allowing the acquisition to proceed. The deal closed in October 2022.
As part of the antitrust settlement, UnitedHealth Group agreed to divest ClaimsXten, Change Healthcare's claims editing business, to TPG Capital for approximately $2.2 billion. This divestiture was completed in 2023.
Following the acquisition, Change Healthcare was integrated into OptumInsight, UnitedHealth Group's healthcare technology and revenue cycle management unit. The integration combined Change Healthcare's claims processing and payment infrastructure with Optum's analytics and revenue cycle services.
On February 21, 2024, Change Healthcare detected a ransomware attack on its systems. The attack, carried out by the BlackCat/ALPHV ransomware group, had actually begun on February 12, 2024, when hackers gained access using compromised credentials on a Citrix remote access portal that lacked multi-factor authentication. The nine-day gap between initial access and detection was later acknowledged by UnitedHealth Group CEO Andrew Witty in testimony before the U.S. Senate. The attack encrypted Change Healthcare's systems and resulted in the theft of approximately six terabytes of data.
The attack caused immediate and widespread disruption to the U.S. healthcare system. Claims processing, eligibility verification, payment processing, and pharmacy benefit transactions were all affected. Hospitals, physician practices, pharmacies, and other healthcare providers experienced delays in claims processing and payment, creating significant financial strain. UnitedHealth Group provided approximately $9 billion in advance funding and loans to affected providers to maintain operations during the outage.
Systems were gradually restored over several months. By April 2024, approximately 80% of functionality was restored. Full restoration of all systems was completed by October 2024.
UnitedHealth Group, through Optum, paid a $22 million ransom to the BlackCat group in Bitcoin in an effort to secure deletion of the stolen data. The data review process took over a year. In October 2024, UnitedHealth Group reported that approximately 100 million individuals were affected. In January 2025, this estimate was revised to 190 million. In August 2025, the final count was confirmed at 192.7 million individuals, making it the largest healthcare data breach in U.S. history. The breach notification process was completed in July 2025, and Change Healthcare's incident call center was closed on August 26, 2025.
As of August 2026, Change Healthcare continues to operate as part of OptumInsight. The company has invested significantly in cybersecurity upgrades, including migration to cloud-based security infrastructure and implementation of multi-factor authentication across all systems.
UnitedHealth Group operates through two primary platforms that work together to deliver comprehensive healthcare solutions: UnitedHealthcare and Optum. This integrated business model enables the company to serve the entire healthcare continuum, from insurance coverage to direct healthcare delivery and technology services, creating synergies that enhance both quality and efficiency.
UnitedHealthcare represents the company's health insurance and benefits division, providing coverage to individuals, employers, and government-sponsored programs including Medicare and Medicaid. In 2025, UnitedHealthcare served 49.8 million consumers and achieved revenues of $344.9 billion, representing 16% growth year-over-year. The division operates through multiple business segments including individual and family plans, employer-sponsored coverage, Medicare Advantage plans, and Medicaid managed care programs.
UnitedHealthcare's success stems from its extensive provider networks, innovative benefit designs, and focus on value-based care models. The company has developed sophisticated approaches to care coordination, preventive health programs, and chronic disease management that improve health outcomes while managing costs effectively. UnitedHealthcare's market leadership position enables it to negotiate favorable terms with healthcare providers and develop innovative insurance products that meet evolving consumer needs.
Optum delivers comprehensive healthcare services and technology solutions through three main segments that support the entire healthcare ecosystem:
Optum Health provides direct patient care and health services, operating clinics, surgical centers, and home health services. The segment employs healthcare professionals including physicians, nurses, and care coordinators who deliver integrated care to patients across various settings. Optum Health focuses on value-based care models that align financial incentives with health outcomes, creating more efficient and effective healthcare delivery systems.
Optum Insight offers data analytics, consulting, and technology services to healthcare organizations, payers, and life sciences companies. The segment leverages UnitedHealth Group's vast healthcare data assets to provide insights that improve clinical outcomes, reduce costs, and enhance operational efficiency. Optum Insight's services include population health management, revenue cycle optimization, and healthcare technology implementation.
Optum Rx manages pharmacy benefits for millions of people, negotiating with pharmaceutical manufacturers and managing prescription drug programs. In 2025, Optum Rx achieved 15% revenue growth, demonstrating strong performance in the pharmacy benefits management market. The segment combines purchasing power with clinical expertise to optimize medication therapy, improve adherence, and manage drug costs effectively.
UnitedHealth Group's integrated business model creates significant competitive advantages. The company's ability to combine insurance coverage with direct healthcare delivery enables better care coordination, improved health outcomes, and more efficient resource utilization. This integration also provides valuable data insights that inform product development, care management programs, and operational improvements.
In 2025, UnitedHealth Group demonstrated exceptional financial performance with consolidated revenues of $447.6 billion, representing 12% growth year-over-year. The company's adjusted earnings from operations reached $21.7 billion, reflecting strong operational execution despite challenges including cyberattack-related costs and business restructuring charges.
In Q2 2026, UnitedHealth Group reported revenues of $112.0 billion and earnings from operations of $8.0 billion, with net margin of 4.9%. Cash flows from operations were $11.1 billion, or 1.9 times net income. UnitedHealthcare served 48.5 million consumers (down from 49.8 million in 2025) and reported Q2 2026 revenues of $86.0 billion with earnings of $3.9 billion. Optum supported over 120 million consumers and generated Q2 2026 revenues of $65.7 billion with earnings of $4.0 billion, representing 160 basis points of margin expansion year over year.
The company's financial metrics demonstrate operational efficiency and strong cash generation. UnitedHealth Group achieved cash flows from operations of $19.7 billion in 2025, representing 1.5 times net income. The company maintains a debt-to-capital ratio of 41.2% (as of June 30, 2026) and targets a long-term ratio of 40.0%, reflecting prudent financial management.
UnitedHealth Group employs approximately 440,000 people worldwide, making it one of the largest employers in the healthcare industry. The company's workforce includes healthcare professionals, technology specialists, data analysts, and business professionals who support the company's integrated healthcare delivery model.
Looking toward 2026, UnitedHealth Group initially established revenue guidance greater than $439.0 billion (a 2% decline reflecting divestitures and membership reduction) and adjusted earnings outlook greater than $17.75 per share. After strong Q2 2026 results, the company raised its full-year 2026 guidance to adjusted net earnings of $19.50 to $20.00 per share, with earnings from operations greater than $25.2 billion. The company expects operating earnings from UnitedHealthcare to exceed $12 billion, Optum Health to exceed $2.2 billion, Optum Insight to exceed $4.9 billion, and Optum Rx to exceed $6.25 billion. Cash flows from operations are expected to be approximately $24 billion, with share repurchases of at least $5 billion.
Change Healthcare's sustainability and ethics considerations are primarily related to data security, healthcare access, and responsible use of health information. As a technology subsidiary of UnitedHealth Group, Change Healthcare operates under UnitedHealth Group's ESG framework.
UnitedHealth Group publishes an annual sustainability report covering environmental, social, and governance topics. The company's environmental initiatives include commitments to reduce greenhouse gas emissions, increase use of renewable energy, and implement sustainable building practices. However, as a technology and services company, Change Healthcare's direct environmental footprint is relatively small compared to manufacturing or extractive industries. The main environmental impact comes from data center energy consumption, which UnitedHealth Group reports is being addressed through efficiency improvements and migration to cloud infrastructure.
The most significant ethical issue facing Change Healthcare is data security and privacy. The February 2024 cyberattack exposed protected health information, Social Security numbers, driver's license numbers, passport numbers, and financial information of approximately 192.7 million individuals. UnitedHealth Group has stated that it is not aware of any misuse of individuals' information as a result of the breach, and no electronic medical record databases appeared in the affected data. However, the breach raised serious questions about Change Healthcare's cybersecurity practices, particularly the failure to implement multi-factor authentication on a remote access portal.
UnitedHealth Group provided complimentary credit monitoring and identity theft protection services to affected individuals. The notification process took over a year to complete, with some individuals potentially never receiving notification due to insufficient address information. The incident call center was closed on August 26, 2025.
Change Healthcare does not hold B Corp certification, cruelty-free certification, or other consumer-facing sustainability certifications, as these are not applicable to a healthcare technology company.
February 2024 Ransomware Attack and Data Breach: On February 21, 2024, Change Healthcare detected a ransomware attack carried out by the BlackCat/ALPHV ransomware group. Hackers had gained access on February 12, 2024, using compromised credentials on a Citrix remote access portal that lacked multi-factor authentication. The attack encrypted Change Healthcare's systems and resulted in the theft of approximately six terabytes of data. UnitedHealth Group, through Optum, paid a $22 million ransom in Bitcoin. The data breach ultimately affected approximately 192.7 million individuals, making it the largest healthcare data breach in U.S. history. The breach notification process was completed in July 2025. UnitedHealth Group reported approximately $2.45 billion in total response costs. This is the most significant controversy associated with Change Healthcare and has resulted in ongoing legal and regulatory consequences.
Healthcare System Disruption (February to October 2024): The ransomware attack caused months of disruption to U.S. healthcare operations. Claims processing, eligibility verification, payment processing, and pharmacy benefit transactions were all affected. Hospitals, physician practices, pharmacies, and other providers experienced delays in claims processing and payment, creating significant financial strain. UnitedHealth Group provided approximately $9 billion in advance funding and loans to affected providers. Some providers reported being unable to process claims or receive payments for weeks, forcing them to take out loans or delay payroll. Full system restoration was completed by October 2024.
Regulatory Investigations: The U.S. Department of Health and Human Services Office for Civil Rights (OCR) launched an investigation into the breach in March 2024, making an unprecedented proactive announcement before Change Healthcare had formally reported the breach. The Senate Finance Committee and Senate Judiciary Committee held hearings in May 2024, at which UnitedHealth Group CEO Andrew Witty testified. In December 2024, Nebraska Attorney General Mike Hilgers became the first state attorney general to file a lawsuit against Change Healthcare over the breach. Multiple state attorneys general have since filed similar lawsuits.
Multi-District Litigation: Lawsuits filed by healthcare providers, patients, and other affected parties against Change Healthcare have been consolidated into multi-district litigation (MDL) in Minnesota federal court. The litigation focuses on security failures, the adequacy of the response, and repayment terms for providers who received advance funding from UnitedHealth Group. As of August 2026, the MDL proceedings are ongoing.
Antitrust Concerns (2021-2022): The U.S. Department of Justice filed a lawsuit in February 2022 to block UnitedHealth Group's acquisition of Change Healthcare, arguing that the deal would reduce competition in healthcare technology markets. A federal judge ruled in UnitedHealth Group's favor in September 2022, allowing the acquisition to proceed. As part of the settlement, UnitedHealth Group divested ClaimsXten, Change Healthcare's claims editing business, to TPG Capital for approximately $2.2 billion. Critics have noted that the acquisition concentrated significant healthcare data infrastructure under a single corporate parent, a concern amplified by the 2024 cyberattack.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Unitedhealth Group | USA | 2011 | Premium | United states | All-ages |
Market Positioning: Change Healthcare competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by UnitedHealth Group, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Change Healthcare which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by EKR Therapeutics, Inc.
Retavase (reteplase) is a prescription thrombolytic medication indicated for acute ST-elevation myocardial infarction. Administered as two 10-unit intravenous bolus injections 30 minutes apart. Currently marketed by Chiesi USA.
Retavase is privately owned, unlike Change Healthcare which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Change Healthcare which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Koninklijke Philips N.V.
Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.
Philips operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.